Your browser doesn't support javascript.
loading
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
Hao, Qiukui; Aertgeerts, Bert; Guyatt, Gordon; Bekkering, Geertruida E; Vandvik, Per Olav; Khan, Safi U; Rodondi, Nicolas; Jackson, Rod; Reny, Jean-Luc; Al Ansary, Lubna; Van Driel, Mieke; Assendelft, Willem J J; Agoritsas, Thomas; Spencer, Frederick; Siemieniuk, Reed A C; Lytvyn, Lyubov; Heen, Anja Fog; Zhao, Qian; Riaz, Irbaz Bin; Ramaekers, Dirk; Okwen, Patrick Mba; Zhu, Ye; Dawson, Annabel; Ovidiu, Mersa Caius; Vanbrabant, Willy; Li, Sheyu; Delvaux, Nicolas.
  • Hao Q; The Center of Gerontology and Geriatrics/National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
  • Aertgeerts B; School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
  • Guyatt G; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Bekkering GE; Department of Public Health and Primary Care and MAGIC Primary Care, Academisch Centrum voor Huisartsgeneeskunde, KU Leuven, Belgium.
  • Vandvik PO; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Khan SU; Department of Public Health and Primary Care and MAGIC Primary Care, Academisch Centrum voor Huisartsgeneeskunde, KU Leuven, Belgium.
  • Rodondi N; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Jackson R; MAGIC Evidence Ecosystem Foundation.
  • Reny JL; Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston TX, USA.
  • Al Ansary L; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Van Driel M; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Assendelft WJJ; School of Population Health, Faculty of Medical & Health Sciences, University of Auckland, New Zealand.
  • Agoritsas T; General Internal Medicine, University Hospital of Geneva, Geneva, Switzerland.
  • Spencer F; Faculty of Medicine, Geneva University, Switzerland.
  • Siemieniuk RAC; Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Lytvyn L; Primary Care Clinical Unit, Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • Heen AF; Department of Primary and Community Care, Radboud University Medical Center, Netherlands.
  • Zhao Q; Division General Internal Medicine & Division of Clinical Epidemiology, University Hospitals of Geneva, Geneva, Switzerland.
  • Riaz IB; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Ramaekers D; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Okwen PM; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Zhu Y; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Dawson A; MAGIC Evidence Ecosystem Foundation.
  • Ovidiu MC; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
  • Vanbrabant W; International Medical Center / Ward of General Practice, West China Hospital, Sichuan University, Chengdu, China.
  • Li S; Department of Medicine, Hematology Oncology, Mayo Clinic, Arziona, USA.
  • Delvaux N; KU Leuven Institute for Healthcare Policy, University of Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium.
BMJ ; 377: e069066, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35508320

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Anticolesterolemiantes / Infarto del Miocardio Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Anticolesterolemiantes / Infarto del Miocardio Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article